pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-449b |
Genomic Coordinates | chr5: 55170646 - 55170742 |
Description | Homo sapiens miR-449b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-449b-5p | ||||||||||||||||||
Sequence | 16| AGGCAGUGUAUUGUUAGCUGGC |37 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Microarray | DRVs in miRNA |
|
||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | GMFB | ||||||||||||||||||||
Synonyms | GMF | ||||||||||||||||||||
Description | glia maturation factor beta | ||||||||||||||||||||
Transcript | NM_004124 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on GMFB | |||||||||||||||||||||
3'UTR of GMFB (miRNA target sites are highlighted) |
>GMFB|NM_004124|3'UTR 1 TGTGAACTTCTGTGTTTCTAAAGTATTTATGTATTAACCTGACCATACTGGAATCAGACATAAATACTTATTTATGCCTA 81 AAAATGCACTGTTACTTACAGTTTGTTTCCTGCAGTAAAGAAAAATTCTTCATTTGTGCAAAATTTGAACAAAGAGGAAA 161 TCATCTTCATAGTAATGAAACTTTGTAAAGTGTTTCCTTATATTGGTAATTGTTAGGTGGACTACTTTTCTCCAGGGACT 241 TTTTGCACTCTTGTGACTAATTTCTATAACTTATGGTTCGGAATTTGTTACTATTTACAGACACCATTGGAAAGTGGATA 321 TATTAGATTGTGAGAGACAACAGTTGCCTCCTTTTGACAAATACTGGATATTAGCAGTTTATTTATGAAAATAGCGTATT 401 ATCACTTGTCAAATCATTGAAATTCATTTGGGGTCAAAGACTTGAGTGACCCAGTATTGAGCCATGAATAATTTAGTGTA 481 ACCTGTATTACAAGTACATTGATGAATTCTGTATCTTCTTTGGTTTCCTGTATCTTTTTAATCAAGTCTAGAAACTATGT 561 TCATCAGTCACTCATTTTTAAGGTCGGGAGTTAGATTTTATGATAGAATTATGACTGTTAGCTTTTCTCCTTATAGCATC 641 TTAGTCTTAGAAATTGGTGGGTTGTAATAATCAAGGGCTTCATTCCTTTTATGTCATTTCTAGACAGTTTTGAATCTAGG 721 TTAATAACACTTTATTTATAAAGCACCTCAATGTCCTGTGAACACTAATTATTTTAAATGTGTTAATACTGTGCCTTTGA 801 TTTGTTAGCTTTAAAGTTAGTTTAAGACTTTTACACTGCCAGTATTCCACATTTGGTGAAATTAATACTTTTTTAAAGGG 881 TCCAAATAAAATAATTTTCTAATGTGTATATCTGAAATTTGTAATAAAATCAACTTCATATTTTAAAAATTCCAACTATC 961 TGCTTGCATTGGTGAATATATGGCAGTCGAGAGTTATAATTTTGGGTATACTTGTGGTTAGTTTTGTGCCATAGGAAAAA 1041 ATTATCTTAAAACTTTGGCCATAGTTAATAACATTAACACTTCAATAGCAATCACATCTTATATCCTAAATGTCAGAAGA 1121 TATTCTGAACTGGATGCCTGAATAGTTAACTAAACCAGTCTTGTTAGATGATGGTACTCTTGGCATAAAGCGAGGATTCT 1201 GATATTTGGCATACTTGTAAAAACAAATACATAAGTAACCATTGAACATTAATTTGATAATAGGTCTAGAGACTCTAAAA 1281 ACTAACCAAACTTGGTGAGTGTATTCTTATATTAAGAATATCTTAGTCATCTCAAAACTAGCAAAATTTAAATTTTGGCA 1361 TGTTTTCCATTCATATGTTCTTTGCATTTTATTTTTGAGGTTTCTGTGAGAAGTAAAGATAGTTGGAATTTTTGCGATAT 1441 TGAATAGAACATCTTCTGTTCCCAACACTGTTTGGCTTCACTAATTTAGAAGTCAGGAAGCAATAGAAAGTTGGAGATGA 1521 GGAAGTGCTAGAGTAGGTGTTTGTTTTGGTTCTTGGAGGGAAAAGATTCTTTATTCCAATTTCCAGAGAGAAGAGAAAAC 1601 TCACCCAGGAAGTTTAAAAATTCTTTAAACAGGTATTTTGATATTGGAGAATAACATGCATATAATTCTGTAGGAATGCA 1681 CATGTAATCCAAGTGAGTGGAGAGTGTTTTTAATGTTTTTGAATGAAGGAAATGAGGTTTTGTTTCACCTGTTTTGCAGC 1761 AGTAAGAGAAACTAGTGCTGCAAGAATGTATTTTTTAATGAAGTTCCTTATTTTGTCTTGCATGTTTTAGTTTTGCTTAT 1841 TTTTAAATTTGGAGGTCCTCCATAATGTCAGATAATATTGACCTGCCATACGTTAGCACTCTTAGTTCCGCTACTGTCTT 1921 TAACAGGAGCAAAGAGCTGTGATAAACCATGCTTTTTTGAGCTTGTCTGACTCCTAATTAATAACATGTTTTTGGCAAGA 2001 CAACAGATTGAGGTTAGAGGATCAGTAGGACATTTTTATTCCATCTGTCCTATGGGGAAATTTACAAATCCCGTGCTCTA 2081 AAATGTTCTCAAACATTTATATAGATTTCCCTTTCATCTTACTAAATTTTGCATTGTTCTTTTCAAGTATGTTTCGTATT 2161 TACTGTCTTTTTTTCTGCCATTTCCCAAATAATAACTCCAGATTTCATAATTCCAGTTTTTACATTCCGTTATCTTTCTG 2241 GTACAACCATTCCCATTCAGCCTTAAATCTGAGTCCTTTTTAGCAGCAACTTTTTTCCTGGGATCCTCCTTCGTGGTCTT 2321 CTAAGTCAGTGTTAGTTTTGAAATTTTTGGCCCTGCATAAGTTCTGCATAGCATCTAATGTCAAAATAGAACCAACTGGT 2401 AATCACAGTATTATTTAGTGTGGTTTCCATGACAACAAAAATACATACGAAGAAAACTTCTCAGGTTACTATGCTGAAAT 2481 TCCAAAATGTCTGAGTTTTGAATAGTGATCACTTTGTTCTGGTATTGACGCAATTATATTAGGAAAAAAGTTGGTTGACT 2561 GTTTTTGTTTAATTGACTTCTAAAATGTTCAAATTGTCTAGTTCTAAAAGTTTACTAAATGCCTAGTGCAGTTAAACATA 2641 CTCTTGTTTAAGTGTGTGTTGCTAAATTTTTTACTGTCATTACTAAATAATCTGTGTGGCAAAATGTGTGTCAGCACTTT 2721 TCCCTCCTTTTTTATCTCCTATTTTCAGGAGTCAAATGTAGCCATAAACTGTATCCTTGTCTGACACTTTAGCTAAAAAT 2801 TTCCAGTTAGGGGAGTTTATTGCCAAATTAAATTTGGCTGTTCCCCCCAACCCATATAGATATTAAGGAAGGTGTACTTA 2881 AAAAATGTTTGGACTGCTTTTAAAACCTGAGCAATGTCATTAATCCATATGTGGACTAGTGATGAATAGATATTTTCATA 2961 AGAGTTTAAATGCTGATATTTGGTGGAAGTAGAGAGTAACTCATATTCTATCAATTCAAGTATTCTTACTATGGTTGCTT 3041 TCCCTATTTGTTCAATAGACTGATAATACTGGAATTTATAGAGTTTGAGCCATTACAACTTTTGTGAGGATGTGTTTCAA 3121 ACATTTCTGGACAAATCTTATTTTGTATTTCTGGAAGAATGTAGTAATCTTCTAGACCGCTTAAAACCAATGCTCCCAAG 3201 CTGAATATTCTTGAGAAATTTGTTTTTATTATGCCATTTGACATTTCAAATCAGTGCTCATATACAGTAAACTTGTGATA 3281 GAAATTGTATTTTATTGCTTTTTGGATTATAATTCATATAAATATAATTACTTGAATATTGTTTGAGATCATTAACATGC 3361 CAGGGCAGTTCCCACTGATTTAGATGGTCCAAGATAATCTCATTCAGGAGGCTTGAAACATTAATGGTTTAGTCTTGTGA 3441 ATTTTAACAGTTCTCTGTCATCGTTTAACAAAACCAACAACTGACACAACTCCTTAAGCTGTGGTTTCAGTCTCTGCTAG 3521 TTCATATTGCATGTTTATTTTGGACAGTCTTTTGTTAAGCATGGTGCTTGTACTGGTTTAAATAAAATGTTAACATT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-1 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796037. RNA binding protein: AGO2. Condition:4-Thiouridine
PAR-CLIP data was present in GSM796038. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796037 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000358056.3 | 3UTR | UUAAGACUUUUACACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM796038 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000358056.3 | 3UTR | UUAAGACUUUUACAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
109 hsa-miR-449b-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT006349 | SIRT1 | sirtuin 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT006350 | CCNE2 | cyclin E2 | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT006351 | MET | MET proto-oncogene, receptor tyrosine kinase | ![]() |
![]() |
2 | 1 | ||||||
MIRT006352 | GMNN | geminin, DNA replication inhibitor | ![]() |
![]() |
2 | 1 | ||||||
MIRT006353 | HDAC1 | histone deacetylase 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT016137 | CDK4 | cyclin dependent kinase 4 | ![]() |
1 | 1 | |||||||
MIRT016138 | CDC25A | cell division cycle 25A | ![]() |
![]() |
2 | 1 | ||||||
MIRT016139 | CDK6 | cyclin dependent kinase 6 | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT057740 | ZDHHC16 | zinc finger DHHC-type containing 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT078636 | FAM104A | family with sequence similarity 104 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT100407 | HSPA1B | heat shock protein family A (Hsp70) member 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT115552 | MAZ | MYC associated zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT130146 | TXNIP | thioredoxin interacting protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT142254 | DCTN5 | dynactin subunit 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT143724 | CCL22 | C-C motif chemokine ligand 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT168101 | E2F3 | E2F transcription factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT169809 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT183694 | MDM4 | MDM4, p53 regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT198922 | SMAD4 | SMAD family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT202950 | TSN | translin | ![]() |
![]() |
2 | 4 | ||||||
MIRT221565 | CBX3 | chromobox 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT253418 | EVI5L | ecotropic viral integration site 5 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT294759 | ZNF551 | zinc finger protein 551 | ![]() |
![]() |
2 | 4 | ||||||
MIRT307053 | TGFBR2 | transforming growth factor beta receptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT331273 | TM9SF3 | transmembrane 9 superfamily member 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT372293 | UBXN2B | UBX domain protein 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT374317 | MBD6 | methyl-CpG binding domain protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445817 | DNAAF3 | dynein axonemal assembly factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447158 | MFSD8 | major facilitator superfamily domain containing 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447823 | CTIF | cap binding complex dependent translation initiation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT448798 | GMFB | glia maturation factor beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT451580 | HIRIP3 | HIRA interacting protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452679 | GPR156 | G protein-coupled receptor 156 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453158 | CNOT4 | CCR4-NOT transcription complex subunit 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT453634 | SLC4A2 | solute carrier family 4 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455384 | PLA2G2D | phospholipase A2 group IID | ![]() |
![]() |
2 | 2 | ||||||
MIRT456958 | SPAM1 | sperm adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462739 | EFNB1 | ephrin B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464321 | UST | uronyl 2-sulfotransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT465641 | TNRC18P2 | trinucleotide repeat containing 18 pseudogene 2 | ![]() |
![]() |
2 | 10 | ||||||
MIRT466748 | SYNGR2 | synaptogyrin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468345 | SF3B3 | splicing factor 3b subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469324 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474361 | KMT2D | lysine methyltransferase 2D | ![]() |
![]() |
2 | 2 | ||||||
MIRT475316 | IFNLR1 | interferon lambda receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477759 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477824 | DYRK3 | dual specificity tyrosine phosphorylation regulated kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478265 | DDX19B | DEAD-box helicase 19B | ![]() |
![]() |
2 | 2 | ||||||
MIRT481042 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT481289 | ATXN1L | ataxin 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT482730 | COPZ1 | coatomer protein complex subunit zeta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488780 | CYTH3 | cytohesin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489578 | SSBP2 | single stranded DNA binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489659 | SHMT1 | serine hydroxymethyltransferase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT490527 | KIAA1715 | lunapark, ER junction formation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT492949 | NEUROD2 | neuronal differentiation 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493154 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493845 | FOXN3 | forkhead box N3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT494743 | ARHGAP1 | Rho GTPase activating protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT496491 | MAST3 | microtubule associated serine/threonine kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT503312 | FICD | FIC domain containing | ![]() |
![]() |
2 | 4 | ||||||
MIRT503507 | ZNF623 | zinc finger protein 623 | ![]() |
![]() |
2 | 2 | ||||||
MIRT504182 | FAM127B | retrotransposon Gag like 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT505010 | ZNF644 | zinc finger protein 644 | ![]() |
![]() |
2 | 2 | ||||||
MIRT505352 | TMEM167A | transmembrane protein 167A | ![]() |
![]() |
2 | 2 | ||||||
MIRT505645 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT505710 | SESN2 | sestrin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT505777 | SATB2 | SATB homeobox 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT506208 | PHF19 | PHD finger protein 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT506251 | PEG10 | paternally expressed 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT507786 | CDKN1B | cyclin dependent kinase inhibitor 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT508005 | BCL2L13 | BCL2 like 13 | ![]() |
![]() |
2 | 4 | ||||||
MIRT508857 | ZRSR1 | zinc finger CCCH-type, RNA binding motif and serine/arginine rich 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT510546 | XBP1P1 | X-box binding protein 1 pseudogene 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT511892 | GAS1 | growth arrest specific 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT512907 | UBL4A | ubiquitin like 4A | ![]() |
![]() |
2 | 2 | ||||||
MIRT513600 | VPS37B | VPS37B, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT521241 | SAR1A | secretion associated Ras related GTPase 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT521321 | RRAGD | Ras related GTP binding D | ![]() |
![]() |
2 | 4 | ||||||
MIRT525281 | C18orf32 | chromosome 18 open reading frame 32 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528650 | RWDD2A | RWD domain containing 2A | ![]() |
![]() |
2 | 4 | ||||||
MIRT535101 | PODXL | podocalyxin like | ![]() |
![]() |
2 | 2 | ||||||
MIRT547752 | KBTBD6 | kelch repeat and BTB domain containing 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT547865 | HSPA13 | heat shock protein family A (Hsp70) member 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT549170 | BMP3 | bone morphogenetic protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT550115 | SLC35G2 | solute carrier family 35 member G2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT556097 | MOAP1 | modulator of apoptosis 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557172 | HOXA13 | homeobox A13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557422 | GXYLT2 | glucoside xylosyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557931 | FAM73A | mitoguardin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568804 | VPS37D | VPS37D, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT571326 | TPCN2 | two pore segment channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572598 | PAPLN | papilin, proteoglycan like sulfated glycoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT573437 | APOPT1 | apoptogenic 1, mitochondrial | ![]() |
![]() |
2 | 2 | ||||||
MIRT574092 | VASN | vasorin | ![]() |
![]() |
2 | 2 | ||||||
MIRT608688 | VAV3 | vav guanine nucleotide exchange factor 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT608800 | ITGA11 | integrin subunit alpha 11 | ![]() |
![]() |
2 | 4 | ||||||
MIRT610332 | SSX5 | SSX family member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT613158 | DDA1 | DET1 and DDB1 associated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625407 | CPEB3 | cytoplasmic polyadenylation element binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636603 | CLIC5 | chloride intracellular channel 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638573 | IER5 | immediate early response 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639686 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT677979 | ITGB3 | integrin subunit beta 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685217 | POTED | POTE ankyrin domain family member D | ![]() |
![]() |
2 | 2 | ||||||
MIRT702570 | JARID2 | jumonji and AT-rich interaction domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706259 | MKLN1 | muskelin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT734675 | HMGB1 | high mobility group box 1 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT736369 | HSPA1A | heat shock protein family A (Hsp70) member 1A | ![]() |
1 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|